Functional estrogen receptor alpha promoter polymorphism is associated with improved endothelial-dependent vasolidation

Area of Science:

• Genetics
• Cardiovascular Biology
• Molecular Endocrinology

Background:

• Estrogen receptor alpha (ERalpha) plays a role in vascular health, influencing endothelial nitric oxide synthase (eNOS) and cholesterol metabolism.
• Genetic variations in ERalpha regulatory regions may impact vascular function.
• A specific single nucleotide polymorphism (T>C) in the ERalpha promoter's negative transcriptional element (ERNE) was identified.

Discussion:

• The ERalpha polymorphism (T>C) was investigated for its association with endothelial-dependent relaxation (EDR) in human saphenous vein.
• Organ bath studies measured EDR in 101 individuals undergoing coronary artery bypass surgery.
• The variant C allele was found to be associated with enhanced EDR, independent of common cardiovascular risk factors.

Key Insights:

• The ERalpha polymorphism abolished the negative regulatory effect of the ERNE element in vitro, leading to increased ERalpha transcription.
• Individuals with the variant C allele exhibited significantly enhanced endothelial-dependent vasorelaxation.
• In males, the C allele was associated with a 225% augmentation of EDR compared to the wild-type allele.

Outlook:

• This functional polymorphism in ERalpha offers a potential genetic marker for vascular function.
• Further research could explore therapeutic strategies targeting ERalpha to improve endothelial health.
• Understanding genotype-phenotype correlations in ERalpha can advance personalized cardiovascular medicine.